Cargando…

Regulation of Mutant p53 Protein Expression

For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijayakumaran, Reshma, Tan, Kah Hin, Miranda, Panimaya Jeffreena, Haupt, Sue, Haupt, Ygal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681805/
https://www.ncbi.nlm.nih.gov/pubmed/26734569
http://dx.doi.org/10.3389/fonc.2015.00284
_version_ 1782405775048572928
author Vijayakumaran, Reshma
Tan, Kah Hin
Miranda, Panimaya Jeffreena
Haupt, Sue
Haupt, Ygal
author_facet Vijayakumaran, Reshma
Tan, Kah Hin
Miranda, Panimaya Jeffreena
Haupt, Sue
Haupt, Ygal
author_sort Vijayakumaran, Reshma
collection PubMed
description For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently, in response to stress conditions, both wt and mutant p53 accumulate in cells. While wt p53 returns to basal level following recovery from stress, mutant p53 remains stable. In part, this can be explained in mutant p53-expressing cells by the lack of an auto-regulatory loop with Mdm2 and other negative regulators, which are pivotal for wt p53 regulation. Further, additional protective mechanisms are acquired by mutant p53, largely mediated by the co-chaperones and their paralogs, the stress-induced heat shock proteins. Consequently, mutant p53 is accumulated in cancer cells in response to chronic stress and this accumulation is critical for its oncogenic gain of functions (GOF). Building on the extensive knowledge regarding wt p53, the regulation of mutant p53 is unraveling. In this review, we describe the current understanding on the major levels at which mutant p53 is regulated. These include the regulation of p53 protein levels by microRNA and by enzymes controlling p53 proteasomal degradation.
format Online
Article
Text
id pubmed-4681805
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-46818052016-01-05 Regulation of Mutant p53 Protein Expression Vijayakumaran, Reshma Tan, Kah Hin Miranda, Panimaya Jeffreena Haupt, Sue Haupt, Ygal Front Oncol Oncology For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently, in response to stress conditions, both wt and mutant p53 accumulate in cells. While wt p53 returns to basal level following recovery from stress, mutant p53 remains stable. In part, this can be explained in mutant p53-expressing cells by the lack of an auto-regulatory loop with Mdm2 and other negative regulators, which are pivotal for wt p53 regulation. Further, additional protective mechanisms are acquired by mutant p53, largely mediated by the co-chaperones and their paralogs, the stress-induced heat shock proteins. Consequently, mutant p53 is accumulated in cancer cells in response to chronic stress and this accumulation is critical for its oncogenic gain of functions (GOF). Building on the extensive knowledge regarding wt p53, the regulation of mutant p53 is unraveling. In this review, we describe the current understanding on the major levels at which mutant p53 is regulated. These include the regulation of p53 protein levels by microRNA and by enzymes controlling p53 proteasomal degradation. Frontiers Media S.A. 2015-12-17 /pmc/articles/PMC4681805/ /pubmed/26734569 http://dx.doi.org/10.3389/fonc.2015.00284 Text en Copyright © 2015 Vijayakumaran, Tan, Miranda, Haupt and Haupt. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Vijayakumaran, Reshma
Tan, Kah Hin
Miranda, Panimaya Jeffreena
Haupt, Sue
Haupt, Ygal
Regulation of Mutant p53 Protein Expression
title Regulation of Mutant p53 Protein Expression
title_full Regulation of Mutant p53 Protein Expression
title_fullStr Regulation of Mutant p53 Protein Expression
title_full_unstemmed Regulation of Mutant p53 Protein Expression
title_short Regulation of Mutant p53 Protein Expression
title_sort regulation of mutant p53 protein expression
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681805/
https://www.ncbi.nlm.nih.gov/pubmed/26734569
http://dx.doi.org/10.3389/fonc.2015.00284
work_keys_str_mv AT vijayakumaranreshma regulationofmutantp53proteinexpression
AT tankahhin regulationofmutantp53proteinexpression
AT mirandapanimayajeffreena regulationofmutantp53proteinexpression
AT hauptsue regulationofmutantp53proteinexpression
AT hauptygal regulationofmutantp53proteinexpression